Across the country, states have begun the first stages of their campaigns to vaccinate people against the novel coronavirus (COVID-19). However, early troubles have highlighted the challenges to such a massive endeavor. Once the first tiers of recipients have been vaccinated, states will need to begin subsequent efforts to inoculate their broader resident populations—efforts that may be hampered by another, more-familiar set of hurdles, including vaccine skepticism and a U.S. health care system that typically leaves large segments of the population underserved.
Looking to the nation’s experiences with other vaccine campaigns such as influenza, can provide insights to the challenges faced by states in attaining their targets for coronavirus immunization.
In an upcoming SHADAC webinar, Senior Research Fellow Colin Planalp, MPA, will present data published in a recent brief, funded by the California Health Care Foundation (CHCF). The analysis uses flu vaccination rates for U.S. adults across the 50 states and the District of Columbia as a proxy to identify population subgroups that may be harder to reach with a COVID-19 vaccine. An analysis of several demographic categories, such as age, race/ethnicity, chronic health conditions, and health insurance coverage status will also be included in the webinar discussion.
Mr. Planalp will also be joined by SHADAC Research Fellow Robert Hest, MPP, for a question and answer session following the webinar presentation.